Overview
Quantum modeling and generative AI-driven drug discovery platform
Funding
Amounts as reported; USD estimates shown only when they matchListed 1 funding record. Latest funding: $22M (Series A+), Nov 14, 2025.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Nov 14, 2025 | $22M · Series A+ | Hongshan China, OrbiMed, Qiming Venture Capital, 一村资本, 成为资本, 芯能创投 | 1 source Source ↗ |
Evidence No source brief is attached to this record. Sources · 1
Hongshan China, OrbiMed, Qiming Venture Capital, 一村资本, 成为资本, 芯能创投 | |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 1 valuation record.
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Nov 14, 2025 | — · Series A+ | Hongshan China, OrbiMed, Qiming Venture Capital, 一村资本, 成为资本, 芯能创投 | 1 source Source ↗ |
Evidence No source brief is attached to this record. Sources · 1
Hongshan China, OrbiMed, Qiming Venture Capital, 一村资本, 成为资本, 芯能创投 | |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
量子建模与生成式 AI 驱动的药物发现研发平台